CONTEMPORARY STRATEGIES FOR EPIDEMIOLOGICAL SURVEILLANCE AND PREVENTION OF NOSOCOMIAL INFECTIONS
Keywords:
nosocomial infections; healthcare-associated infections; HAI surveillance; infection prevention and control; CLABSI; VAP; disinfection; sterilization; care bundles; hospital epidemiologyAbstract
Nosocomial infections (NIs), also termed healthcare-associated infections (HAIs), represent a major source of preventable morbidity, mortality, and healthcare expenditure in both high-income and resource-constrained settings. The most common HAI types — central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), surgical site infections (SSIs), and ventilator-associated pneumonia (VAP) — collectively affect an estimated 7–10% of all hospitalized patients worldwide. This review synthesizes current evidence on the epidemiology of nosocomial infections, their principal transmission mechanisms, modern surveillance methodologies, and evidence-based prevention strategies including disinfection and sterilization protocols, bundle-based care, and digital surveillance tools. Clinical examples from ICU and surgical ward settings are integrated to illustrate practical implementation.
References
1. World Health Organization. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. Geneva: WHO; 2011. Updated data 2022. Available from: https://www.who.int/publications/i/item/9789241501507
2. Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, et al. Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med. 2016;13(10):e1002150. DOI: 10.1371/journal.pmed.1002150
3. Klompas M, Branson R, Cawcutt K, Crist M, Eichenwald EC, Greene LR, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2022;43(6):687–713. DOI: 10.1017/ice.2022.88
4. Magill SS, O'Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):1732–1744. DOI: 10.1056/NEJMoa1801550
5. World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. Geneva: WHO; 2009 [Updated implementation evidence 2021]. Available from: https://www.who.int/publications/i/item/9789241597906
6. Anderson DJ, Chen LF, Weber DJ, Moehring RW, Lewis SS, Triplett PF, et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study). Lancet. 2017;389(10071):805–814. DOI: 10.1016/S0140-6736(16)31588-4
7. Streefkerk HRAA, Verkooijen RP, Breijer S, Polinder-Bos HA, Paltansing S, Vos MC. Automated and semi-automated electronic HAI surveillance systems: a systematic review. J Hosp Infect. 2023;131:1–10. DOI: 10.1016/j.jhin.2022.11.001
8. Mathers AJ, Stoesser N, Chai W, Carroll J, Barry K, Cherunvanky A, et al. Whole-genome sequencing of Klebsiella pneumoniae and Enterobacter species reveals multiple nosocomial transmission events. J Clin Microbiol. 2021;59(4):e01928-20. DOI: 10.1128/JCM.01928-20
9. Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O'Grady NP, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2023;44(4):553–569. DOI: 10.1017/ice.2023.26
10. Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N Engl J Med. 2022;386(3):220–229. DOI: 10.1056/NEJMoa2106516